LEADER 10934nam 2200553 450 001 9910488710303321 005 20230424161643.0 010 $a3-030-73299-1 035 $a(CKB)5590000000517262 035 $a(MiAaPQ)EBC6676054 035 $a(Au-PeEL)EBL6676054 035 $a(OCoLC)1258658440 035 $a(PPN)269153187 035 $a(EXLCZ)995590000000517262 100 $a20220328d2021 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aOrthopedic stem cell surgery /$fJeffrey N. Weiss 210 1$aCham, Switzerland :$cSpringer,$d[2021] 210 4$d©2021 215 $a1 online resource (281 pages) 311 $a3-030-73298-3 311 $a3-030-73301-7 320 $aIncludes bibliographical references and index. 327 $aIntro -- Preface -- Contents -- Part I: Rotator Cuff Repair -- 1: Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair -- Summary -- Intervention -- Outcome Measures -- Primary Outcome -- Secondary Outcome -- Functional Outcome -- Patient-Centered Outcome -- Eligibility -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 2: Bone Marrow-Derived Stem Cells for the Treatment of Rotator Cuff Tears -- Summary -- Intervention -- Outcome Measures -- Primary Outcome -- Secondary Outcome -- Inclusion Criteria -- Exclusion Criteria -- 3: Regenexx? SD Versus Exercise Therapy for Rotator Cuff Tears -- Summary -- Intervention -- Outcome Measures -- Primary Outcome -- Secondary Outcome -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 4: Safety and Efficacy of Adult Adipose-Derived Stem Cell Injection into Partial-Thickness Rotator Cuff Tears -- Summary -- Intervention -- Outcome Measures -- Primary Outcome -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 5: Autologous Adult Adipose-Derived Regenerative Cell Injection into Chronic Partial-Thickness Rotator Cuff Tears -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Other Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 6: Clinical Study on Mesenchymal Stem Cells Used in the Reconstruction Surgery of the Supraspinatus Muscle Lesions -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 7: Efficacy of Microfragmented Lipoaspirate Tissue in Arthroscopic Rotator Cuff Repair -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 8: Mesenchymal Stem Cells in Rotator Cuff Repair -- Summary. 327 $aIntervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 9: Treatment of Tendon Disease Using Autologous Adipose-Derived Mesenchymal Stem Cells -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 10: Adipose-Derived Mesenchymal Stem Cells in Osteoarthritis -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Criteria -- Inclusion Criteria -- Exclusion Criteria -- Part II: Knee Osteoarthritis -- 11: Impact of Mesenchymal Stem Cells in Knee Osteoarthritis -- Summary -- Intervention -- Outcome Measures -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Knee Osteoarthritis Subjects -- Focal Chondral Defect Subjects -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 12: Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES) -- Summary -- Intervention -- Outcome -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 13: Early Regenerative Intervention for Post-Traumatic Osteoarthritis (ERIPTO) -- Summary -- Intervention -- Outcome Measures -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 14: Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 15: Open-Ended Trocar Vs. Fenestrated Blunt Trocar in Bone Marrow Aspirate for Osteoarthritis -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Secondary Outcome Measures -- Other Outcome Measures -- Eligibility Criteria -- Inclusion Criteria -- Exclusion Criteria. 327 $a16: The Effect of Microfragmented Adipose Tissue (MFAT) on Knee Osteoarthritis -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Secondary Outcome Measures -- Other Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 17: A Disease-Based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-Derived Regenerative Cells -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Secondary Outcome Measures -- Other Outcome Measures -- Inclusion -- All Cohorts -- Inclusion Criteria-All Cohorts -- Ankle Cohort -- Hip Cohort -- Knee Cohort -- Shoulder Cohort -- Wrist Cohort -- Exclusion Criteria-All Cohorts -- Ankle Cohort -- Hip Cohort -- Knee Cohort -- Shoulder Cohort -- Wrist Cohort -- 18: Stem Cell and Growth Factor Injury and Arthritis Clinical Research Study -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 19: Adipose-derived Mesenchymal Stem Cells in Osteoarthritis -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Scoring and Interpretation -- Secondary Outcome Measures -- Methods -- Inclusion Criteria -- Exclusion Criteria -- 20: Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Secondary Outcome Measures -- Methods -- Inclusion Criteria -- Exclusion Criteria -- 21: A Study Evaluating the Efficacy of a Single Injection Autologous Adipose-Derived Mesenchymal Stromal Cells in Patients with Knee Osteoarthritis (ADIPOA-2) -- Summary -- Intervention -- Outcome -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 22: Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair (AURA) -- Summary -- Detailed Description -- Primary Outcome Measures. 327 $aSecondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 23: Subchondral and Intra-articular Application of Bone Marrow Concentrate for Knee Unicompartmental OA (Marrow Mule) -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 24: Treatment of Early Knee Osteoarthritis with Autologous Adipose-Derived Mesenchymal Stem Cells -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 25: Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 26: Very Small Embryonic-Like Stem Cells for Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 27: Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Other Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 28: Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 29: Treatment of Knee Osteoarthritis with Autologous Adipose-Derived Mesenchymal Stem Cells -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 30: Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis -- Summary. 327 $aIntervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 31: Mesenchymal Stem Cell Transplantation for Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 32: Effectiveness of Autologous Adipose-Derived Stem Cells in the Treatment of Knee Cartilage Injury -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 33: Adipose-Derived Stem Cells (ADSCs) for Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 34: Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 35: Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients with Knee Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 36: Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- Further Reading -- 37: Follow-Up Study for Participants of JointStem Clinical Trial -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria -- 38: A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in the Treatment of Osteoarthritis -- Summary -- Intervention -- Primary Outcome Measures -- Secondary Outcome Measures -- Inclusion Criteria -- Exclusion Criteria. 327 $a39: Follow-Up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial. 606 $aOrthopedics 606 $aCèl·lules mare$2thub 606 $aOrtopèdia$2thub 608 $aLlibres electrònics$2thub 615 0$aOrthopedics. 615 7$aCèl·lules mare 615 7$aOrtopèdia 676 $a616.7 700 $aWeiss$b Jeffrey N.$0927848 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910488710303321 996 $aOrthopedic Stem Cell Surgery$92193163 997 $aUNINA